Real World Oncology in China

You Have Questions.
We Get Answers.

Since 2015, GenomiCare has been a pioneer in guiding patient-centered precision medical care for Chinese cancer patients through direct patient engagement, complete genomic profiling, and close collaboration with physicians and hospitals.

GenomiCare Biotechnology provides pharmaceutical and biotech companies with real world insights into key differences in cancer treatment and disease management in China, enabling both their research and commercial programs.  

ISPOR Webinar- China RWE/RWD

On June 29th, GenomiCare Biotechnology hosted an ISPOR webinar about the opportunities/challenges of RWE/RWD collection from China.

GenomiCare Scientific Advisory Board Member Dr. Chen Lieping is elected by National Academy of Sciences as new member

GenomiCare is proud to announce On April 27, 2021, the National Academy of Sciences (NAS) announced the latest list of newly elected members, including Dr. Chen Lieping, a member of the GenomiCare Scientific Advisory Board (SAB).

GenomiCare Is on List of 2020 Deloitte China Technology Fast 50 & China Rising Star

The 2020 China Technology Fast 50 & China Rising Star lists were officially published by the Beijing office of Deloitte on December 9 and reported by dozens of news outlets. GenomiCare is on list of the 2020 China Rising Star thanks to its “two-wheel-drive” business model, powerful translational cancer research, and flexible data solutions for clinical oncology drug development.

Clinical Network

Across China, we partner with 1,200+ leading physicians and 200+ hospitals, including a unique partnership with Jiahui hospital in Shanghai, and its collaborating US counterpart Massachusetts General Hospital.

Longitudinal Real World Data Integration

We collect and curate consented,  longitudinal clinical data on each of our patients across multiple institutions, and combine these data with state-of-the-art genomics data.

Prospective Cohort Expansion

Sponsor-directed cohort expansions using our extensive clinical network

Quality Data

Fully integrated expert curation of clinical and molecular data

Dynamic real-time cohort analysis

AI-driven real time analysis generating real time analysis

Global Access

Fully compliant, secured portal access for real-time analysis

We are very pleased with the high quality of the real-world data provided by GenomiCare, and the fast, in-depth technical support from its scientists and developers. The team at GenomiCare helped us immensely with full data access and implementation of customized computational pipelines. The professional bioinformatics team delivered high-quality real-world evidence, sound analysis results, and remarkable reports that helped our cancer drug discoveries.”

Agios Pharmaceuticals